The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
Authors
Keywords
-
Journal
BMC INFECTIOUS DISEASES
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-17
DOI
10.1186/s12879-020-4781-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives
- (2018) Femke de Velde et al. PHARMACOLOGICAL RESEARCH
- How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients
- (2018) Aaron J. Heffernan et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Association between increased mortality rate and antibiotic dose adjustment in intensive care unit patients with renal impairment
- (2018) Marianne Silveira Camargo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
- (2017) T. Tängdén et al. INTENSIVE CARE MEDICINE
- Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships
- (2017) Sahand Imani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Simultaneous determination of nine β-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography–tandem mass spectrometry
- (2017) Alan Abdulla et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study
- (2016) INTENSIVE CARE MEDICINE
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
- (2016) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Outcomes of Patients With Prolonged Intensive Care Unit Length of Stay After Cardiac Surgery
- (2016) Pey-Jen Yu et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis*
- (2015) David Zhang et al. CRITICAL CARE MEDICINE
- Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study
- (2015) Angela Huttner et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development
- (2015) Mohd Abdul-Aziz et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy
- (2013) Barbara O.M. Claus et al. JOURNAL OF CRITICAL CARE
- The ciprofloxacin target AUC : MIC ratio is not reached in hospitalized patients with the recommended dosing regimens
- (2012) Michiel Haeseker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An Antimicrobial Stewardship Program’s Impact with Rapid Polymerase Chain Reaction Methicillin‐ResistantStaphylococcus aureus/S. aureusBlood Culture Test in Patients withS. aureusBacteremia
- (2010) Karri A. Bauer et al. CLINICAL INFECTIOUS DISEASES
- First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
- (2009) Jason A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches
- (2008) Jean-Marie Conil et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections
- (2008) Peggy S. McKinnon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study
- (2008) Arthur R.H. van Zanten et al. JOURNAL OF CRITICAL CARE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started